AMY F MILLER

Allopathic & Osteopathic Physicians|Family Medicine MIDLOTHIAN, VA NPI 1811962095

General Payments — all program years on this page

$2,882.70

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 181
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $356.80 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $208.8815
Sumitomo Pharma America, Inc. $78.611
GlaxoSmithKline, LLC. $30.322
Inspire Medical Systems, Inc. $24.641
Novo Nordisk AS $14.351

By program year

Program yearAmountRecords
2018 $273.2317
2019 $454.7916
2020 $262.6716
2021 $625.7540
2022 $461.7440
2023 $447.7232
2024 $356.8020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096615680 Novo Nordisk Inc $14.35 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035403 ABBVIE INC. $19.01 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035405 ABBVIE INC. $23.09 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035407 ABBVIE INC. $15.10 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035409 ABBVIE INC. $15.51 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035411 ABBVIE INC. $0.66 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035413 ABBVIE INC. $16.39 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035415 ABBVIE INC. $16.61 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035417 ABBVIE INC. $28.13 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035419 ABBVIE INC. $18.76 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035421 ABBVIE INC. $16.48 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035423 ABBVIE INC. $0.68 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035425 ABBVIE INC. $0.80 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035427 ABBVIE INC. $19.19 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035429 ABBVIE INC. $17.79 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105035431 ABBVIE INC. $0.68 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116331148 GlaxoSmithKline, LLC. $14.15 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116697881 GlaxoSmithKline, LLC. $16.17 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148083230 Inspire Medical Systems, Inc. $24.64 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148890905 Sumitomo Pharma America, Inc. $78.61 07/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.